Evidence map›Paper›PMID 28774900›Full record

ArticleScience (New York, N.Y.)2017

UBE2O remodels the proteome during terminal erythroid differentiation.

Anthony T Nguyen, Miguel A Prado, Paul J Schmidt, Anoop K Sendamarai, Joshua T Wilson-Grady, Mingwei Min, Dean R Campagna, Geng Tian, Yuan Shi, Verena Dederer and 9 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 175 citations in OpenAlex.

  1. Substrate biasing in UCHL5 proteoforms.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Ribosome-associated quality control and related mechanisms.Nature structural & molecular biology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Impact of protein degradation and cell growth on mammalian proteomes.bioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. Article
  17. Ribosome-associated proteins: unwRAPping ribosome heterogeneity in the twenty-first century.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  18. Article
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Anthony T NguyenDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-0181-4623
Miguel A PradoDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-4914-1619
Paul J SchmidtDepartment of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Anoop K SendamaraiDepartment of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-0476-5428
Joshua T Wilson-GradyDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-6919-0410
Mingwei MinDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Dean R CampagnaDepartment of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-3893-0257
Geng TianDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-8807-5669
Yuan ShiDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-9993-0448
Verena DedererDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Mona KawanDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-7789-2404
Nathalie KuehnleDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-4668-8712
Joao A PauloDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-4291-413X
Yu YaoDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0001-9286-4014
Mitchell J WeissDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Monica J JusticeGenetics and Genome Biology Program, Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, Toronto, Ontario M5G 0A4, Canada.ORCID 0000-0003-3562-2099
Steven P GygiDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-7626-0034
Mark D FlemingDepartment of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA. mark.fleming@childrens.harvard.edu daniel_finley@hms.harvard.edu.ORCID 0000-0003-0948-4024
Daniel FinleyDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. mark.fleming@childrens.harvard.edu daniel_finley@hms.harvard.edu.ORCID 0000-0003-2076-5863
Harvard University · USBoston Children's Hospital · USSt. Jude Children's Research Hospital · USHospital for Sick Children · CA

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
MUTATIONS IN DEVELOPMENTAL PATHWAYS BY ENU MUTAGENESISU01HD039372 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI JUSTICE, MONICA JEAN · 2000 to 2005
$17.3M
Genetic analysis of mouse chromosome 11R01CA115503 · NCI · BAYLOR COLLEGE OF MEDICINE · PI JUSTICE, MONICA J. · 2006 to 2010
$2.6M
A novel program of ubiquitination in global remodeling of the erythroid proteomeR01HL125710 · NHLBI · HARVARD MEDICAL SCHOOL · PI FINLEY, DANIEL J, FLEMING, MARK D · 2015 to 2018
$1.9M
Resolving the role of nicotine-mediated phosphorylation on pancreatic fibrosisK01DK098285 · NIDDK · HARVARD MEDICAL SCHOOL · PI PAULO, JOAO A · 2013 to 2017
$638k
Ubiquitination in erythropoiesis and the pathophysiology of anemiaR21HL116210 · NHLBI · HARVARD MEDICAL SCHOOL · PI FINLEY, DANIEL J, FLEMING, MARK D · 2012 to 2013
$477k
A ubiquitin-conjugating enzyme critical for terminal erythroid differentiationF30HL124980 · NHLBI · HARVARD MEDICAL SCHOOL · PI NGUYEN, ANTHONY TUAN · 2014 to 2015
$83k
NCI NIH HHS R01 CA115503NHLBI NIH HHS F30 HL124980NHLBI NIH HHS R01 HL125710NHLBI NIH HHS R21 HL116210NICHD NIH HHS U01 HD039372NIDDK NIH HHS K01 DK098285NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

During terminal differentiation, the global protein complement is remodeled, as epitomized by erythrocytes, whose cytosol is ~98% globin. The erythroid proteome undergoes a rapid transition at the reticulocyte stage; however, the mechanisms driving programmed elimination of preexisting cytosolic proteins are unclear. We found that a mutation in the murine

Indexed as

UbiquitinationAnemiaAnemia, HypochromicAnimalsbeta-GlobinsErythrocytesErythroid CellsErythropoiesisHEK293 CellsHumansMiceMice, Inbred C57BLMice, Mutant StrainsMutationProteasome Endopeptidase ComplexProteomebeta-GlobinsProteasome Endopeptidase ComplexProteomeRibosomal ProteinsUbe2o protein, mouseUbiquitin-Conjugating Enzymes

Identifiers

PMID28774900
PMCPMC5812729
OpenAlexW2743753720

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.